Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis. En savoir plus sur Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.
Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors. En savoir plus sur Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors.
Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated August 2018. En savoir plus sur Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated August 2018.
Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study. En savoir plus sur Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study.